Reimann I W, Klotz U, Siems B, Frölich J
Br J Clin Pharmacol. 1981 Dec;12(6):785-90. doi: 10.1111/j.1365-2125.1981.tb01307.x.
1 The influence of cimetidine (1000 mg daily) on propranolol steady state plasma levels has been studied in seven normal volunteers. Cimetidine was used as a 200 mg normal release tablet whereas propranolol was given as a 160 mg slow release formulation once daily. 2 After 1 day of cimetidine treatment (day 9 of the study) the mean (Css) and minimal (Css min) propranolol steady state plasma levels increased significantly from 24.1 +/- 14.9 ng/ml (mean +/- s.d.) to 39.2 +/- 27.7 ng/ml (P = 0.01) and from 14.8 +/- 9.3 ng/ml to 27.1 +/- 21.2 ng/ml (P = 0.03), respectively. The apparent oral clearance (Clo) was reduced from 6.7 +/- 4.3 l/min to 4.6 +/- 3.11/min (P = 0.006). 3 A prolongation of cimetidine administration to 5 days (day 13 of the study) intensified this effect significantly (P = 0.02): Css of propranolol was elevated from 23.2 +/- 14.4 ng/ml to 44.9 +/- 26.7 ng/ml (P = 0.003); Css min was increased from 14.1 +/- 10.2 ng/ml to 28.4 +/- 17.9 ng/ml (P = 0.02) while Clo decreased from 6.9 +/- 4.1 1/min to 3.3 +/- 1.61/min (P = 0.006). 4 We conclude that the drug interaction between propranolol and cimetidine leads to significant elevations of propranolol steady state plasma concentrations which may cause a clinically relevant enhancement of the effect of a given dosage. This requires careful observation of patients under concomitant treatment with propranolol and cimetidine.
研究了西咪替丁(每日1000毫克)对7名正常志愿者体内普萘洛尔稳态血浆水平的影响。西咪替丁采用200毫克普通释放片剂,而普萘洛尔则每日服用一次160毫克缓释制剂。
西咪替丁治疗1天后(研究的第9天),普萘洛尔的平均稳态血浆水平(Css)和最低稳态血浆水平(Css min)显著升高,分别从24.1±14.9纳克/毫升(平均值±标准差)升至39.2±27.7纳克/毫升(P = 0.01),以及从14.8±9.3纳克/毫升升至27.1±21.2纳克/毫升(P = 0.03)。表观口服清除率(Clo)从6.7±4.3升/分钟降至4.6±3.1升/分钟(P = 0.006)。
将西咪替丁给药延长至5天(研究的第13天),这种效应显著增强(P = 0.02):普萘洛尔的Css从23.2±14.4纳克/毫升升至44.9±26.7纳克/毫升(P = 0.003);Css min从14.1±10.2纳克/毫升升至28.4±17.9纳克/毫升(P = 0.02),而Clo从6.9±4.1升/分钟降至3.3±1.6升/分钟(P = 0.006)。
我们得出结论,普萘洛尔与西咪替丁之间的药物相互作用导致普萘洛尔稳态血浆浓度显著升高,这可能会使给定剂量的效果在临床上有显著增强。这就要求在普萘洛尔和西咪替丁联合治疗的患者中进行仔细观察。